Heterologous expression of the novel α-helical hybrid peptide PR-FO in Bacillus subtilis

Licong Zhang,Dandan Wei,Na Zhan,Taotao Sun,Bingdong Shan,Anshan Shan
DOI: https://doi.org/10.1007/s00449-020-02353-1
IF: 3.434
2020-04-29
Bioprocess and Biosystems Engineering
Abstract:PR-FO is a novel α-helical hybrid antimicrobial peptide (AMP) with strong antimicrobial activities and high stability, and the potential to develop into a new generation of antimicrobial agents. In this study, the encoded gene sequence of SMT3-PR-FO was designed and transformed into <i>B. subtilis</i> WB800N. Fusion proteins with concentrations of 16 mg L<sup>−1</sup> (SP<sub><i>amyQ</i></sub>) and 23 mg L<sup>−1</sup> (SP<sub><i>sacB</i></sub>) were obtained after purification by a Ni–NTA resin column. A total of 3 mg (SP<sub><i>amyQ</i></sub>) and 4 mg (SP<sub><i>sa</i>c<i>B</i></sub>) of PR-FO with a purity of 90% was obtained from 1 L fermentation cultures. Recombinant PR-FO exhibited high inhibition activities against both gram-negative bacteria and gram-positive bacteria, and low haemolytic activity against human red blood cells. These results indicated that the rSMT3-PR-FO could be expressed under the guidance of SP<sub><i>amyQ</i></sub> and SP<sub><i>sacB</i></sub>, and the maltose-induced expression strategy might be a safe and efficient method for the soluble peptides production in <i>B. subtilis.</i>
engineering, chemical,biotechnology & applied microbiology
What problem does this paper attempt to address?